Literature DB >> 12090335

Current problems and needs in the treatment of pT1 G3 bladder carcinoma.

Francisco Jose Martínez Portillo1, Peter Alken.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12090335     DOI： 10.1023/a:1014492517088

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN： 0301-1623            Impact factor:   2.370


× No keyword cloud information.
  59 in total

1.  Local recurrence and survival following nerve-sparing radical cystoprostatectomy.

Authors:  C B Brendler; G D Steinberg; F F Marshall; J L Mostwin; P C Walsh
Journal:  J Urol       Date:  1990-11       Impact factor: 7.450

Review 2.  Natural history of superficial bladder cancer. Prognostic features and long-term disease course.

Authors:  N M Heney
Journal:  Urol Clin North Am       Date:  1992-08       Impact factor: 2.241

3.  Uncertainty and outcome of invasive bladder tumors.

Authors:  H W Herr
Journal:  Urol Oncol       Date:  1996 May-Jun       Impact factor: 3.498

Review 4.  [Therapy of superficial bladder carcinoma].

Authors:  H Rübben; D Jocham
Journal:  Urologe A       Date:  1991-01       Impact factor: 0.639

Review 5.  Multivariate analysis of the prognostic factors of primary superficial bladder cancer.

Authors:  F Millán-Rodríguez; G Chéchile-Toniolo; J Salvador-Bayarri; J Palou; J Vicente-Rodríguez
Journal:  J Urol       Date:  2000-01       Impact factor: 7.450

6.  Effects of local bacillus Calmette-Guerin therapy in patients with bladder carcinoma on immunocompetent cells of the bladder wall.

Authors:  A Böhle; J Gerdes; A J Ulmer; A G Hofstetter; H D Flad
Journal:  J Urol       Date:  1990-07       Impact factor: 7.450

7.  Pharmacokinetics of intravesical mitomycin C in superficial bladder cancer patients.

Authors:  J T Dalton; M G Wientjes; R A Badalament; J R Drago; J L Au
Journal:  Cancer Res       Date:  1991-10-01       Impact factor: 12.701

8.  Bladder wall penetration of intravesical mitomycin C in dogs.

Authors:  M G Wientjes; J T Dalton; R A Badalament; J R Drago; J L Au
Journal:  Cancer Res       Date:  1991-08-15       Impact factor: 12.701

9.  Cystectomy for superficial bladder cancer.

Authors:  R B Bracken; M W McDonald; D E Johnson
Journal:  Urology       Date:  1981-11       Impact factor: 2.649

10.  Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression.

Authors:  A S Sarkis; G Dalbagni; C Cordon-Cardo; Z F Zhang; J Sheinfeld; W R Fair; H W Herr; V E Reuter
Journal:  J Natl Cancer Inst       Date:  1993-01-06       Impact factor: 13.506
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.